Teriflunomide Patent Expiration
Teriflunomide is Used for treating patients with relapsing forms of multiple sclerosis. It was first introduced by Sanofi Aventis Us Llc
Teriflunomide Patents
Given below is the list of patents protecting Teriflunomide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Aubagio |
US9186346 (Pediatric) | Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients | Aug 04, 2034 | Sanofi Aventis Us |
| Aubagio | US9186346 | Methods for reducing the risk of an adverse teriflunomide and rosuvastatin interaction in multiple sclerosis patients | Feb 04, 2034 | Sanofi Aventis Us |
| Aubagio |
US8802735 (Pediatric) | (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability | Mar 14, 2031 | Sanofi Aventis Us |
| Aubagio | US8802735 | (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability | Sep 14, 2030 | Sanofi Aventis Us |
| Aubagio |
US6794410 (Pediatric) | Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4′-trifluoromethylphenyl)-amide for treating multiple sclerosis | Mar 12, 2027 | Sanofi Aventis Us |
| Aubagio | US6794410 | Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4′-trifluoromethylphenyl)-amide for treating multiple sclerosis | Sep 12, 2026 | Sanofi Aventis Us |
| Aubagio | US5679709 | Medicaments to combat autoimmune diseases |
Oct 21, 2014
(Expired) | Sanofi Aventis Us |
| Aubagio | US5459163 | Medicament to combat autoimmune diseases |
Oct 17, 2012
(Expired) | Sanofi Aventis Us |
Teriflunomide's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List